Jump to ContentJump to Main Navigation
Conflicts of Interest and the Future of MedicineThe United States, France, and Japan$

Marc A. Rodwin

Print publication date: 2011

Print ISBN-13: 9780199755486

Published to Oxford Scholarship Online: May 2011

DOI: 10.1093/acprof:oso/9780199755486.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2017. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in OSO for personal use (for details see http://www.oxfordscholarship.com/page/privacy-policy). Subscriber: null; date: 26 February 2017

(p.331) Bibliography

(p.331) Bibliography

Source:
Conflicts of Interest and the Future of Medicine
Publisher:
Oxford University Press

  • JAMA

    Journal of the American Medical Association

  • NEJM

    New England Journal of Medicine

Bibliography references:

Abe, Maratoshi. 1985. Japan’s clinic physicians and their behavior. Social Science and Medicine 20 (4): 333–40.

Abraham, Jennifer Campbell, and Susan Mickler. 1983. The role of social pressure, attention to the stimulus and self-doubt in conformity. European Journal of Social Psychology 13 (3): 217–33.

Abramson, John. 2004. Overdo$ed America: The broken promise of American medicine. New York: Harper.

Adams, Samuel Hopkins. 1905. The great American fraud. New York: P. F. Collier and Son.

Adams, Thomas McStay. 1990. Bureaucrats and beggars: French social policy in the age of the Enlightenment. New York: Oxford University Press.

Als-Nielsen, Bodil, Wendong Chen, Christian Glund, et al. 2003. Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? JAMA 290 (7): 921–28.

Altman, Stuart H., and Marc A. Rodwin. 1988. Halfway competitive markets and ineffective regulation: The American health care system. Journal of Health Politics, Policy and Law 13 (2): 323–39.

American Board of Internal Medicine (ABIM) Foundation, American College of Physicians (ACP), American Society of Internal Medicine (ASIM) Foundation, and European Federation of Internal Medicine. 2002. Medical professionalism in the new millennium: A physician charter. Annals of Internal Medicine 136 (3): 243–46.

American College of Surgeons (ACS). 1959. Position of American College of Surgeons on proration of insurance payments. Bulletin of the American College of Surgeons 44 (1): 5–8.

American Medical Association (AMA). 1900. Secret nostrums and the journal. JAMA 34 (22): 1420.

American Medical Association (AMA). 1902. Association News. JAMA 38 (25): 1661.

American Medical Association (AMA). 1907. Hospital and dispensary abuse. JAMA 48 (7): 613–15. Reprinted 2007, JAMA 297 (6): 651.

American Medical Association (AMA). 1907. Medical economics: Contract practice. JAMA 49 (24): 2028–29.

(p.332) American Medical Association (AMA). 1925. Hospital service in the United States. JAMA 84 (13): 961–67.

American Medical Association (AMA). 1933. Medical economics: Private group practice. JAMA 100 (21): 1693–99.

American Medical Association (AMA). 1986. Report of the Council on Ethical and Judicial Affairs, A (I-86): Conflicts of interest.

American Medical Association (AMA), Bureau of Economics. 1934. The insurance principle in the practice of medicine. JAMA 102 (19): 1612–18.

American Medical Association (AMA), Bureau of Medical Economics. 1934. A critical analysis of sickness insurance. Chicago: AMA.

American Medical Association (AMA), Council on Judicial Affairs (CEJA). 1991. Conflicts of interest: Physician ownership of medical facilities, Report C (I-91).

American Medical Association, Council on Pharmacy and Chemistry. 1905. Report of the Council. JAMA 40:265–66.

American Medical Association, Council on Pharmacy and Chemistry. 1905. The secret nostrum vs. the ethical proprietary preparation. JAMA 40 (8): 718–19.

American Medical Association (AMA), Council on Pharmacy and Chemistry. 1955. New program of operation for evaluation of drugs. JAMA 158 (13): 1170–72.

American Medical Association (AMA), House of Delegates. 1903. Principles of medical ethics. Available at http://www.ama-assn.org/ama1/pub/upload/mm/43/1903principlesofethi.pdf (accessed 10 November 2009).

American Medical Association (AMA), House of Delegates. 1934. Sickness insurance problems in the United States. JAMA 102 (26): 2200–2201.

American Medical Association (AMA), House of Delegates. 1989. Physicians’ involvement in commercial ventures: Status report. Proceedings (December): 131–32.

American Medical Association (AMA), House of Delegates. 1942–present. Proceedings.

American Medical Association (AMA), Organization Section, 1942. JAMA 111 (1): 59–60.

Ameringer, Carl F. 1999. State medical boards and the politics of public protection. Baltimore, MD: Johns Hopkins University Press.

Ameringer, Carl F. 2008. The health care revolution: From medical monopoly to market competition. Berkeley: University of California Press.

Andersen, Morten, Jakob Kragstrup, and Jens Sondergaard. 2006. How conducting a clinical trial affects physicians’ guideline adherence and drug preferences. JAMA 295 (23): 2759–64.

Anderson, Odin W., Patricia Collette, and Jacob J. Feldman. 1963. Changes in family medical expenditures and voluntary health insurance: A five-year resurvey. Cambridge, MA: Harvard University Press.

Angel, Marcia. 2004. The truth about drug companies: How they deceive us and what to do about it. New York: Random House.

Annas, George J. 1974. The hospital: A human rights wasteland. Civil Liberties Review 1 (4): 9–29.

Annas, George J. 1975. The rights of hospital patients. New York: Avon.

Annas, George J. 2006. Hunger strikes at Guantanamo: Medical ethics and human rights in a legal black hole. NEJM 355 (13): 1377–82.

Annas, George J. 2009. Globalized clinical trials and informed consent. NEJM 360 (20): 2050–53.

(p.333) Annas, George J., and Michael A. Grodin. 1995. The Nazi doctors and the Nuremburg Code: Human rights in human experimentation. New York: Oxford University Press.

Aoki, I. 1988. Shōki iryō-riyō kumiai no shōsō, Han-Nan Rōnshū [Evolution of early state of medical co-operatives society, Social Science] 24 (1988): 1–18, 41–55 (in Japanese).

Applebaum, Leon. 1961. The development of voluntary health insurance in the United States. Journal of Risk and Insurance 28 (3): 25–33.

Appelbaum, Paul S., Charles W. Lidz, and Alan Meisel. 1987. Informed consent: Legal theory and clinical practice. New York: Oxford University Press.

Arai, Ko. 2006. Reforming hospital costing practices in Japan: An implementation study. Financial Accountability & Management 22 (4): 425–51.

Arrow, Kenneth J. 1963. Uncertainty and the welfare economics of medical care. American Economic Review 53 (5): 941–73.

Arrow, Kenneth J. 1973. Social responsibility and economic efficiency. Public Policy 21 (Summer): 303–17.

Audere, Y., et G. Delteil. 1994. La médecine malade de l’argent. Paris: Edition de l’Atelier.

Baker, Tom. 2005. The medical malpractice myth. Chicago: University of Chicago Press.

Barber, Bernard. 1963. Some problems in the sociology of the professions. Daedalus 92 (43): 669–88.

Barth, Caroline, and Richard Vargas. 2001. Quand l’ordre règne: L’ordre des médecins en question. Paris: Mango Document.

Bazzoli, Gloria J., Stephen M. Shortell, Nicole Dubbs, et al. 1999. A taxonomy of health networks and systems: Bringing order out of chaos. Health Services Research 33 (3): 1683–717.

Bekelman, Justin E., Yan Li, and Cary P. Gross. 2003. Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 289 (4): 454–65.

Benaiche, Lionel. 2004. Expertise en santé publique et principe de précaution. Report for the Ministry of Justice and the Ministry of the Economy, Finance, and Industry. 12 August.

Béraud, Claude. 1992. Le rapport Béraud. Le Concours Médical 114, no. 30 (3 October): 2616–2724.

Berlant, Jeffrey Lionel. 1975. Profession and monopoly: A study of medicine in the United States and Great Britain. Berkeley: University of California Press.

Berman-Sandler, Leatrice. 2004. Independent medical review: Expanding legal remedies to achieve managed care accountability. Annals of Health Law 13 (1): 233–302.

Bevan, Arthur Dean. 1928. Cooperation in medical education and medical services: Functions of the medical profession, of the university and of the public. JAMA 90 (15): 1173–77.

Bickman, Leonard. 1974. The social power of a uniform. Journal of Applied Social Psychology 4 (1): 47–61.

Blau, Peter M. 1964. Exchange and power in social life. New York: John Wiley.

Blum, John. 1993. Evaluation of medical staff using fiscal factors: Economic credentialing. Journal of Health and Hospital Law 26 (3): 65–72, 82.

(p.334) Blumenthal, David. 1994. The vital role of professionalism in health care reform. Health Affairs 13 (1): 252–56.

Bodenheimer, Thomas. 2000. Uneasy alliance: Clinical investigators and the pharmaceutical industry. NEJM 342 (20): 1539–42.

Bosk, Charles L. 1979. Forgive and remember: Managing medical failure. Chicago: University of Chicago Press.

Bosk, Charles L. 2006. Avoiding conventional understandings: The enduring legacy of Eliot Friedson. Sociology of Health & Illness 28 (5): 637–53.

Bourgeois, Léon. 1896. Solidarité. Paris: Armand Colin.

Bowman, John G. 1919. General hospitals of 100 or more beds. Bulletin of the American College of Surgeons 5 (1): 66–69.

Bowman, Marjorie A. 1986. The impact of drug company funding on the content of continuing medical education. Mobius 6 (1): 66–69.

Bowman, Marjorie A., and David L. Pearle. 1988. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. Journal of Continuing Education in the Health Professions 8 (1): 13–20.

Brennan, Troyen A. 1994. Buying editorials. NEJM 331 (10): 673–75.

Brint, Steven. 1994. In an age of experts: The changing role of professionals in politics and public life. Princeton, NJ: Princeton University Press.

Brockliss, Laurence, and Colin Jones. 1997. The medical world of early modern France. New York: Oxford University Press.

Brown, Lawrence D. 1983. Politics and health care organization: HMOs as federal policy. Washington, DC: Brookings Institution.

Brown, Lawrence D., and Elizabeth Eagan. 2004. The paradoxical politics of provider reempowerment. Journal of Health Politics, Policy and Law 29 (6): 1045–72.

Buchmueller, Thomas C., and Agnès Couffinhal. 2004. Private health insurance in France. Organization for Economic Cooperation and Development (OECD), Health Working Papers, No. 12. ESLSA/ELSA/WD/HEA (2004)3. Available at http://www.oecd.org/dataoecd/35/11/30455292.pdf (accessed 10 November 2009).

Buckland, William W. [1911] 1983. Equity in Roman law. London: University of London Press; reprint Buffalo, NY: William S. Hein.

Buckland, William W., and Arnold McNair. [1936] 1952. Roman law and common law: A comparison in outline. Cambridge: Cambridge University Press.

Burdick, William L. 1938. The principles of Roman law and their relation to modern law. Rochester, NY: Lawyers Co-operative.

Burrows, James G. 1977. Organized medicine in the Progressive era: The move toward monopoly. Baltimore, MD: Johns Hopkins University Press.

Cain, Daylian M., George Loewenstein, and Don A. Moore. 2005. The dirt on coming clean: Perverse effects of disclosing conflicts of interest. Journal of Legal Studies 34 (1): 1–23.

Calabro, Sheryl. 2004. Breaking the shield of the learned intermediary doctrine: Placing the blame where it belongs. Cardozo Law Review 25 (6): 2241–16.

Campbell, Eric, Russell Gruen, James Mountford, et al. 2007. A national survey of physician-industry relationships. NEJM 356 (17): 1742–50.

Campbell, John Creighton, and Naoki Ikegami. 1998. The art of balance in health policy: Maintaining Japan’s low-cost, egalitarian system. New York: Cambridge University Press.

(p.335) Cantin-Cumyn, Madeleine. 1992. L’avant projet de loi relatif a la fiducie: un point de vue civiliste d’outre-atlantique. Paris: Recueil Dalloz, 117–21.

Carlson, Robert. 1999. Is there a physician union in your future? Family Practice Management 6 (1): 21–25.

Carr-Saunders, Alexander Morris, and P. A. Wilson. 1933. The Professions. Oxford: Clarendon Press.

Casalino, Lawrence P. 1992. Balancing incentives: How should physicians be reimbursed? JAMA 267 (3): 403.

Catrice-Lorey, Antoinette. 1982. La dynamique interne de la sécurité sociale, du système de pouvoir à la fonction personnelle. Paris: Economica.

Chadalat, Jean‑François. 2003. La répartition des interventions entre les assurances maladies obligatoires et complémentaires en matière de dépense de santé. Paris: Commission des comptes de la sécurité sociale.

Champy, Florent. 2009. La Sociologie des professions. Paris: Presses Universitaires France.

Chase-Lubitz, Jeffrey F. 1987. The corporate practice of medicine doctrine: An anachronism in the modern health care industry. Vanderbilt Law Review 40 (2): 445–88.

Chatriot, Alain. 2002. La démocratie sociale à la française: L’expérience du conseil national économique 1924–1940. Paris: Éditions la Découverte.

Chevit, P. 1978. L’ordre des médecins. Thèse de Médecine, Faculté de Médecine de St. Antoine, Paris.

Chino, Tetsurō. 2007. An economic analysis of institutions and regulations in the Japanese healthcare system. Government Auditing Review 14 (March): 13–25.

Choudhry, Niteesh K., Henry Thomas Stelfox, and Allan S. Detsky. 2002. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287 (5): 612–17.

Chren, Margaret M., and C. Seth Landefeld. 1994. Physicians’ behavior and their interactions with drug companies: A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 271 (9): 684–89.

Cialdini, Robert B. 1993. Influence: Science and practice. New York: HarperCollins.

Cibrié, Paul. 1954. Syndicalisme médical. Paris: Confédération des Syndicat Médicaux Français.

Clapesattle, Helen. 1941. The doctors Mayo. Minneapolis: University of Minnesota Press.

Cohen, Deborah, and Philip Carter. 2010. WHO and the pandemic flu “conspiracies.” British Medical Journal 340 (7759): 1274–79.

Colby, Mark A. 2004. The Japan healthcare debate: Diverse perspectives. Folkestone: Global Oriental.

Commission on Financing Hospital Care. 1955. Prepayment and community. In Financing of hospital care in the United States, vol. 2, ed. Harry Becker. New York: Blakiston.

Committee on Cost of Medical Care. 1932. Medical care for the American people: Final report. Reprinted in U.S. DHEW, Public Health Service. 1970. Health Services and Mental Health Administration, Community Health Services. Washington, DC: Government Printing Office.

Corteze, Nathan. 2008. International health care convergence: The benefits and burdens of market-driven standardization. Wisconsin International Law Journal 26 (3): 646–704.

(p.336) Cosgrove, Lisa, Sheldon Krimsky, Manisha Vijayaraghavan, et al. 2006. Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics 75 (3): 154–60.

Couffinhal, Agnès, and Valérie Paris. 2001. Utilization fees imposed to public heath care system users in France. Available at http://www.irdes.eu/EspaceAnglais/Publications/OtherPubs/UtilisationFeesImposedFrance.pdf (accessed 10 November 2009).

Couffinhal, Agnès, and Valérie Paris. 2003. Cost sharing in France. Working Paper. Available at http://www.irdes.fr/english/wp/CostSharing.pdf (accessed 10 November 2009).

Council for the Promotion of Regulatory Reform (CPRR). 2004. First report on the promotion of regulatory reform and the opening up of government-driven markets for entry into the private sector. 24 December. Available at http://www8.cao.go.jp/kisei-kaikaku/old/publication/2004/1224/item041224_02e.pdf (accessed 1 September 2010).

Cunningham, Robert III, and Robert Cunningham, Jr. 1997. The Blues: A history of the Blue Cross and Blue Shield system. DeKalb: Northern Illinois University Press.

Dana, Jason, and George Loewenstein. 2003. A social science perspective on gifts to physicians from industry. JAMA 290 (2): 252–55.

Davis, Loyal. 1960. Fellowship of surgeons: A history of the American College of Surgeons. Springfield, IL: Charles C. Thomas.

De Kervasdoué, Jean. 1980. La politique d’État en matière d’hospitalisation privée (1962–1978), analyse des conséquences contradictoires. Les Annales Economiques 16:25–56.

De Kervasdoué, Jean, ed. 2000. Le carnet de santé de la France 2000. Paris: Mutualité Française/Editions Dunod.

De Kervasdoué, Jean, ed. 2003. Le carnet de santé de la France 2003. Paris: Mutualité Française/Editions Dunod.

De Kervasdoué, Jean, ed. 2009. Le carnet de santé de la France 2009: Economie, droit et politiques de santé. Paris: Dunod.

De Kervasdoué, Jean. 2009. Très chèr santé. Paris: Perrin.

De Kervasdoué, Jean, et Rémi Pellet, eds. 2002. Le carnet de santé de la France 2000–2002. Paris: Editions Dunod.

De Kervasdoué, Jean, et Rémi Pellet, eds. 2006. Le carnet de santé de la France 2006: Economie, droit et politiques de sante. Paris: Dunod.

De Kervasdoue, Jean, et Henri Picheral, eds. 2004. Le carnet de santé de la France 2004: Santé et territoire. Paris: Editions Dunod.

Delaunay, Paul. 1906. Le monde médical Parisien au dix-huitième siècle. Paris: Jules Rousset.

Delaunea, Paul. 1935. La vie médicale aux XVIIe et XVIIIe siècles. Paris: Hippocrate.

Delcheva, Eugenia, Dinva Balabanova, and Martin McKee. 1997. Under-the-counter payments for health care: Evidence from Bulgaria. Health Policy 42 (2): 89–100.

Desrosieres, Alain. 1977. Éléments pour l’histoire des nomenclatures professionnelles. In Pour une histoire de la statistique, Tome 1, INEE.

Desrosieres, Alain, and Laurent Théveont. 2002. Les catégories socio-professionnelles. Paris: La Découverte.

Dorsey, E. Ray, Jason de Roulet, Joel P. Thompson, et al. 2010. Funding of US biomedical research, 2003–2008. JAMA 30(2): 137–43.

(p.337) Dossier Special. 2007. La fiducie. Recueil Dalloz 20: 1346–74.

Douglas, Paul. 1932. The French social insurance act. Annals of the American Academy of Political and Social Science 164 (1): 211–48.

Dowling, Harry F. 1970. Medicines for man: The development, regulation and use of prescription drugs. New York: Alfred A. Knopf.

Dowling, Harry F. 1970. The American Medical Association’s policy on drugs in recent decades. In Safeguarding the public: Historical aspects of medicinal drug control, ed. J. B. Blake, 123–31. Baltimore, MD: Johns Hopkins University Press.

Downing, W. L., and Paul R. Hawley. 1952. Two physicians speak their minds on fee-splitting. Bulletin of the American College of Surgeons 37 (4): 388–90, 392–93.

Dreyfus, Michel. 1988. La mutualité: Une histoire maintenant accessible. Paris: Mutualité Française.

Dryer, Owen. 2004. Journal rejects article after objections from marketing department. British Medical Journal 328 (7434): 244.

Dubar, Claude, et Pierre Tripier. 1998. Sociologie des professions. Paris: Armand Colin.

Dupeyroux, Jean-Jacques, Michel Borgetto, et Robert Lafore. 2008. Droit de la sécurité sociale. 16ème ed. Paris: Dalloz.

Duriez, M., P. Lancry, D. Lequet-Slama, et S. Sandier. 1999. Le système de santé en France. Paris: Presses Universitaires de France.

Durkheim, Émile. 2008 [1912]. The elementary forms of religious life. Translated by Joseph Ward Swain. Mineola, NY: Dover Publications, Inc.

Durkeim, Émile. 2008 [1893]. The division of labor in society. Translated by George Simpson. New York: Free Press.

Dutton, Paul V. 2002. Origins of the welfare state: The struggle for social reform in France, 1914–1947. New York: Cambridge University Press.

Dutton, Paul V. 2004. La médecine libérale rencontre le médecin syndicaliste (1920–1930). Bulletin de l’Histoire de la Sécurité Sociale 49:79–98.

Dutton, Paul V. 2007. Differential diagnoses: A comparative history of health care problems and solutions in the United States and France. Ithaca, NY: Cornell University Press.

Ehrenreich, Barbara, and Jon Ehrenreich. 1970. The American health empire. New York: Random House.

Ellis, R. P., and Thomas G. McGuire. 1986. Provider behavior under prospective payment. Journal of Health Economics 5 (2):129–51.

English Regulatory Information Task Force, Japan Pharmaceutical Manufacturers Association. 2008. Pharmaceutical administration and regulations in Japan, 166–67. Available at http://www.jpma.or.jp/english/ or http://www.nihs.go.jp/English/index.htpl (accessed 10 November 2009).

Europe stratégie analyse financière (EUROSTAF). 1996. Les cliniques privées: Perspectives stratégiques et financières. Paris: EUROSTAF.

Evans, C. L. 1912. Sic vos non vobis. Journal of the Missouri State Medical Association 8 (April): 405–6.

Evleth, Donna. 2006. The ordre des medecins and the Jews in Vichy France, 1940–1944. French History 20 (2): 204–24.

Evleth, Donna. 2009. La bataille pour l’ordre des médecins, 1944–1950 Le Mouvement Social 229 (Octobre–décembre): 61–77.

Faden, Ruth R., and Thomas L. Beauchamp. 1986. A theory and history of informed consent. New York: Oxford University Press.

(p.338) Falit, Benjamin. 2007. Curbing industry sponsors’ incentive to design post-approval trials that are suboptimal for informing prescribers but more likely than optimal designs to yield favorable results. Seton Hall Law Review 37 (4):969–1049.

Falk, Isadore Sydney. 1936. Security against sickness: A study of health insurance. Garden City, NY: Doubleday, Doran.

Federation of Pharmaceutical Manufacturer Associations of Japan. 1976. Code of practices for the promotion of ethical drugs. Tokyo: Federation of Pharmaceutical Manufacturer Associations of Japan.

Fein, Rashi, 1986. Medical care, medical cost: The search for a national health insurance policy. Cambridge, MA: Harvard University Press.

Feldman, Eric A. 1994. Legal transplants, organ transplants: The Japanese experience. Social and Legal Studies: An International Journal 3 (1):71–91.

Feldman, Eric. 2000. Blood justice: Courts, conflict, and compensation in Japan, France, and the United States. Law and Society Review 34 (3):651–702.

Feldman, Eric. 2000. The ritual of rights in Japan: Law, society, and health policy. New York: Cambridge University Press.

Feldman, Eric. 2009. Suing doctors in Japan: Structure, culture, and the rise of malpractice litigation. In Fault lines: Tort law as cultural practice, ed. M. McCann and D. Engel, 211–32. Stanford, CA: Stanford University Press.

Ferber, Robert, and Hugh G. Wales. 1958. The effectiveness of pharmaceutical promotion. University of Illinois Bureau of Economic and Business Research Bulletin No. 83.

Ferrer, Jose M. 1975. How are the costs of continuing medical education to be defrayed? Bulletin of the New York Academy of Medicine 5 (6):785–88.

Festinger, Leon. 1950. Informal social communication. Psychology Review 57 (5): 271–82.

Field, Mark G. 1953. Structured strain in the role of the Soviet physician. American Journal of Sociology 58 (5): 493–502.

Finkelstein, Stan, and Peter Temin. 2008. Reasonable Rx: Solving the drug price crisis. Upper Saddle River, NJ: FT Press.

Fishbein, Morris. 1934. Sickness insurance and sickness costs. Chicago: AMA

Fishbein, Morris. 1947. A history of the American Medical Association: 1847 to 1947. Philadelphia: W.B. Saunders.

Flanagin, Annette, Lisa A. Carey, Phil B. Fontanarosa, et al. 1998. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA 280 (3): 222–24.

Flexner, Abraham. 1910. Medical education in the United States and Canada. New York: Carnegie Foundation for the Advancement of Teaching.

Flexner, Abraham. 1911. Medical colleges: The duty of the state to suppress bad ones and to support good ones. The World’s Work 21:1438–42.

Fligstein, Neil. 2001. The architecture of markets. Princeton, NJ: Princeton University Press.

Frangos, John. 1997. From housing the poor to healing the sick: The changing institution of Paris hospitals under the old regime and revolution. Madison, WI: Associated University Presses.

Frankford, David M. 1989. Creating and dividing the fruits of collective economic activity: Referrals among health care providers. Columbia Law Review 89 (8): 1861–938.

(p.339) Freidson, Eliot. 1970. Professional dominance: The social structure of medical care. New York: Atherton.

Freidson, Eliot. 1973. Professions and the occupational principle. In The Professions and their prospects, ed. Eliot Freidson, 19–38. Beverly Hills, CA: Sage. Reprinted 2001 in Freidson, Professionalism reborn, 61–74.

Freidson, Eliot. 1983. Occupational autonomy and labor market shelters. In Varieties of work, ed. P. L. Steward and M. G. Cantor, 39–54. Beverly Hills, CA: Sage.

Freidson, Eliot. 1984. Doctoring together: A study of professional social control. Chicago: University of Chicago Press.

Freidson, Eliot. 1988. Professional powers: A study of institutionalization of formal knowledge. Chicago: University of Chicago Press.

Freidson, Eliot. 2001. Professionalism: The third logic. Chicago: University of Chicago Press.

Freidson, Eliot. 2001. Professionalism reborn: Theory, prophecy, and policy. Chicago: University of Chicago Press.

Friedman, Lawrence M. 1965. Freedom of contract and occupational licensing 1890–1910: A legal and social study. California Law Review 53 (1): 487–534.

Friedman, Milton, and Simon Kuznets. 1945. Income from independent professional medical practice. New York: National Bureau of Economic Research.

Fuchs, Victor R. 1996. Economics, values and health care reform. American Economic Review 86 (1): 1–24.

Fuji, Ryoji. 2009. The reform of health care system and complementary health insurance in France. The Japanese Journal of Social Security Policy 8 (2): 57–67.

Fukuhara, Shunichi, Chikao Yamazaki, Yasuaki Hayashino, et al. 2007. The organization and financing of end-stage renal disease. International Journal of Health Care Finance and Economics 7 (2): 217–31.

Funk, Edwin. 1967. Yesterday, today and tomorrow in drug advertising. Drug Advertising, Pharmaceutical Marketing and Media 2 (March): 13–16.

Fuse, Shouichi. 1979. Ishi no rekisi [History of doctors—its Japanese characteristics]. (Tokyo: Chūō Kōronsha, 1979).

Gabel, Jon. 1997. Ten ways HMOs have changed during the 1990s. Health Affairs 16 (3): 134–45.

Gaffin, Ben. 1961. Report on a study of advertising and the American physician, part 1. Based on Ben Gaffin and Associates. 1956. Fond du Lac study: An intensive study of the marketing of five new ethical pharmaceutical products in a single market, resulting in some theory of scientific marketing and service programs for action. Chicago: AMA. Reprinted in U.S. Senate, Hearing, Subcommittee on Antitrust and Monopoly. Drug industry antirust act (1961–1962), pt. 1, 490–529.

Gagnon, Marc-André, and Joel Lexchin. 2008. The cost of pushing ills: A new estimate of pharmaceutical promotion expenditures in the United States. PLoS Medicine 5 (1). Available at http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0050001 (accessed 10 November 2009).

Gallant, Henry C. 1955. Histoire politique de la sécurité sociale française 1945–1952. Paris: Cahiers de la Fondation Nationale des Sciences Politiques.

Garai, Pierre R. 1964. Advertising and promotion of drugs. In Drugs in our society, ed. P. Talalay, 189–202. Baltimore, MD: Johns Hopkins University Press.

Gawande, Atul. 2009. The cost conundrum. New Yorker, 1 June, 36–44.

(p.340) Gibbons, Robert, Frank J. Landry, Denise Blouch, et al. 1998. A comparison of physicians and patients’ attitudes toward pharmaceutical industry gifts. Journal of General Internal Medicine 13 (3): 151–54.

Gilb, Corinne Lathrop. 1976. Hidden hierarchies: The professions and government. Westport, CT: Greenwood Press.

Ginzberg, Eli, ed. 1991. Health service research: Key to health policy. Cambridge, MA: Harvard University Press.

Glasser, Stephen, Maribel Salas, and Elizabeth Delzell. 2007. Importance and challenges of studying marketed drugs: What is a phase IV study? Common clinical research designs, registries, and self-reporting system. Journal of Clinical Pharmacology 47 (9): 1074–86.

Gold, Marsha R., and Ingrid Reeves. 1987. Preliminary results of the GHAA-BC/BS survey of physician incentives in health maintenance organizations (HMOs). Research Briefs 1 (November): 1–15.

Gold, Marsha, Timothy Lake, and Robert Hurley. 2001. Provider organizations at risk: A profile of major risk bearing intermediaries, 1999. Health Affairs 20 (2): 175–85.

Goldsmith, Jeff. 1981. Can hospitals survive? The new competitive health care market. Homewood, IL: Dow Jones-Irwin.

Goode, William J. 1969. The theoretical limits of professionalization. In The semi-professions and their organizations, ed. Amitai Etzioni, 266–313. New York: Free Press.

Gopnik, Adam. 1995. Private domain. New Yorker, 13 November, 74–80.

Gordon, Andrew. 1985. The evolution of labor relations in Japan: Heavy industry 1853–1955. Cambridge, MA: Council on East Asian Studies, Harvard University.

Graunder, T. M. 1980. On the readability of surgical consent forms. NEJM 302 (16): 900–902.

Gray, Bradford H., and Marilyn J. Fields, eds. 1989. Controlling costs and changing patient care: The role of utilization management. Washington, DC: National Academy Press.

Greene, Jeremy A. 2007. Pharmaceutical marketing research and the prescribing physician. Annals of Internal Medicine 146 (10): 742–47.

Greene, Jeremy A., and Scott H. Podolsky. 2009. Keeping modern in medicine: Pharmaceutical promotion and physician education in postwar America. Bulletin of the History of Medicine 83 (2): 331–77.

Greer, Scott L. 2008. Becoming European: How France, Germany, Spain and the UK engage with European Union health policy. London: the Nuffield Trust. http://www.nuffieldtrust.org.uk/ecomm/files/Becoming-European-191108.pdf (accessed, 12 May 2010).

Greer, Scott L. 2009. The politics of European Union health policies. Maidenhead, Berks, England: Open University Press.

Greenwood, Ernest. 1957. Attributes of a profession. Social Work 2 (3): 45–55.

Grossman, J. M., and B. C. Strunk. 2004. For-profit conversions and merger trends among Blue Cross Blue Shield health plans: Issue brief. Center for Studying Health System Change 76 (January): 1–6.

Gruen, Russell L., Steven D. Pearson, and Troyen A. Brennan. 2004. The physician citizens: Public roles and professional organizations. JAMA 291 (1): 94–98.

(p.341) Guillaume, Pierre. 1995. La préhistoire de l’Ordre des médecins. In L’exercice médical dans la société: Hier, aujourd’hui, demain. Contributions au colloque organisé par l’Ordre national des médecins les 29 et 30 Septembre 1995 à Paris, 273–84. Paris: Masson.

Guillaume, Pierre. 1996. Le rôle social du médecin depuis deux siècles: 1800–1945. Paris: Association pour l’Etude de l’histoire de la Sécurité Sociale.

Guillaume, Pierre. 2000. Mutualistes et médecins: Conflits et convergences, XIXe-XXe siècles. Paris: Editions de l’Atelier/Editions Ouvrières.

Haayer, Flora. 1982. Rational prescribing and sources of information. Social Science and Medicine 16 (23): 2017–23.

Hafferty, Frederic W., and John B McKinlay,.eds. 1993. The changing medical profession: An international perspective. New York: Oxford University Press.

Hager, Mary, Sue Russell and Suzanne W. Fletcher. 2009. Continuing education in the health professions: Improving healthcare through lifelong learning. New York: Josiah Macy, Jr. Foundation. Available at www.joshiahmacyfoundation.org.

Hall, Mark A. 1988. Institutional control of physician behavior: Legal barriers to health care cost containment. University of Pennsylvania Law Review 137 (2): 431–536.

Hansen, Horace R. 1958. Group health plans: A twenty-year legal review. Minnesota Law Review 42 (4): 527–48.

Harichaux, Michele. 1979. La rémunération du médecin. Paris: Economica.

Harris, Richard. 1964. The real voice. New York: Macmillan.

Hassenteufel, Patrick. 1997. Les médecins face à 1’état: Une comparaison européenne. Paris: Presses de Sciences Po.

Hatzfeld, Henri. 1963. Le grand tournant de la médecine libérale. Paris: Les Éditions Ouvrières.

Hatzfeld, Henri. 1971. Du paupérisme à la sécurité sociale, 1850–1940. Paris: Armand Colin.

Havighurst, Clark C. 1983. The doctors’ trust: Self-regulation and the law. Health Affairs 2 (3): 64–76.

Havighurst, Clark C. 1980. Antitrust enforcement in the medical services industry: What does it all mean? The Milbank Quarterly 58 (1): 89–124.

Havlicek, Penny L., Ann Eiler, and Ondria T. Neblett. 1993. Medical groups in the United States: A survey of practice characteristics. Chicago: AMA.

Haward, J. E. S. 1959. Solidarity: The social history of an idea in 19th century France. International Review of Social History 4: 261–64.

Haward, J. E. S. 1961. The official social philosophy of the French third republic: Léon Bourgeois and Solidarism. International Review of Social History 6:19–48.

Hawkins, Norman G. 1959. The detailman and preference behavior. Southwestern Social Science Quarterly 40:213–24.

Hawley, Paul R. 1952. American College of Surgeons restates principles of financial relations. Bulletin of the American College of Surgeons 37 (3): 233–36.

Health Care Advisory Board. 1989. Physician bonding, vol. 2. Perfecting the physician network. Washington, DC: Advisory Board Company.

Hellinger, Fred. J. 1996. The impact of financial incentives on physician behavior in managed care plans: A review of the evidence. Medical Care Research and Review 53 (3): 294.

(p.342) Henderson, L. E., R. L. Sensenich, and Ernest E. Irons. 1949. Medicine in Japan: A report to General Douglas MacArthur, SCAP. JAMA 139 (18): 1277–83.

Herzlich, Claudine. 1982. The evolution of relations between French physicians and the state from 1880 to 1980. Sociology of Health and Illness 4 (3): 241–53.

Hibbard, Judith H., Paul Slovic, and Jacquelyn J. Jewett. 1997. Informing consumer decisions in health care: Implications from decision-making research. Milbank Quarterly 75 (3): 395.

Higuchi, Norio. 1999. Fuideyusharii (shinnin) no jidai: Shintaku to keiyaku [The age of fiduciaries: Trusts and contracts]. Tokyo: Yuhikaku.

Hildreth, Martha L. 1987. Doctors, bureaucrats, and public health in France, 1888–1902. New York: Garland.

Hildreth, Martha L. 1987. Medical rivalries and medical politics in France: The physicians’ union movement and the medical assistance law of 1893. Journal of the History of Medicine and the Allied Sciences 42 (1): 5–29.

Hillman, Allan L., W. Pete Welch, and Mark V. Pauly. 1992. Contractual arrangements between HMOs and primary care physicians: Three-tiered HMOs and risk pools. Medical Care 30 (2): 136–48.

Himmelstein, David U., Elizabeth Warren, Deborah Thorne, et al. 2005. Illness and injury as contributors to bankruptcy. Health Affairs W (5): 63–73.

Hirsh, Bernard D. 1984. History of the judicial council of the American Medical Association. Chicago: AMA.

Hoffer, George E. 1974. Physician-ownership in pharmacies and drug repackagers. Inquiry 12 (1): 26–36.

Holmes, Wendell H., and Symeon C. Symedonides. 1999. Representation, mandate, and agency: A commentary on Louisiana’s new law. Tulane Law Review 73 (4): 1087–159.

Hoy, Elizabeth W., Richard E. Curtis, and Thomas D. Rice. 1991. Change and growth in managed care. Health Affairs 10 (4): 18–36.

Hughes, Everett C. 1971. The sociological eye. Chicago: Aldine.

Hyman, David, and Joel V. Williamson. 1988. Fraud and abuse: Regulatory alternatives in a competitive health care era. Loyola University of Chicago Law Journal 19 (4): 1131–96.

Iglehardt, John K. 1988. Japan’s medical system, Part I, NEJM 319 (12): 807–12.

Iglehardt, John K. 1988. Japan’s medical system, Part II. NEJM 319 (17): 1166–72.

Ikegami, Naoki. 1988. Health technology development in Japan. International Journal of Technology Assessment in Health Care 4 (2): 239–54.

Ikegami, Naoki. 1989. Economic aspects of the doctor-patient relationship in Japan from the eighteenth century until the emergence of social insurance. In History of the doctor-patient relationship: Proceedings of the 14th international symposium on the comparative history of medicine—East and West, ed. Y. Kawakita, S. Sakai, and Y. Otsuka, 131–46. Tokyo: Ishiyaku EuroAmerica.

Ikegami, Naoki. 1991. Japanese health care: Low cost through regulated fees. Health Affairs 10 (3): 87–109.

Ikegami, Naoki. 1994. Efficiency and effectiveness in health care. Daedalus 123 (4): 113–25.

Ikegami, Naoki. 2006. Should providers be allowed to extra-bill for uncovered services? Debate, resolution and the sequel in Japan, Journal of Health Politics, Policy and Law 31 (6): 1129–49.

(p.343) Ikegami, Naoki. 2009. Games policy makers and providers play: Introducing case-mix-based payment to hospital chronic care units in Japan. Journal of Health Politics Policy and Law 34 (3): 361–80.

Ikegami, Naoki, and John Creighton Campbell. 1995. Medical care in Japan. NEJM 333 (19): 1295–99.

Ikegami, Naoki, and John Creighton Campbell. 1999. Health care reform: The virtues of muddling through. Health Affairs 18 (3): 56–75.

Illich, Ivan. 1976. Medical nemesis: The expropriation of health. New York: Pantheon Books.

Immergut, Ellen M. 1992. Health politics: Interest and institution in Western Europe. Cambridge: Cambridge University Press.

Inoue, Mitsusada, Kazuo Kasahara, and Kota Kodama. 1975. Japan’s history. Tokyo: Yamakawa.

Institut de Recherche et documentation en Economie de la Santé. 2004. Sickness funds reform; new governance: France Survey no. 4: 2004. Health Policy Monitor. International Network Health Policy and Reform Bertelsmann Stiftung Foundation. Available at http://www.healthpolicymonitor.org/index.jsp (accessed 10 November 2009).

Institut de Recherche et documentation en Economie de la Santé. 2005. Hospital payment reform survey. Health Policy Monitor 5. International Network Health Policy and Reform Bertelsmann Stiftung Foundation. Available at http://www.healthpolicymonitor.org/index/jsp (accessed 10 November 2009).

Institute of Medicine, Board on Health Sciences and Policy. 2009. Conflict of interest in medical research, education, and practice, ed. Bernard Lo and Marilyn Field. Washington, DC: National Academy of Sciences.

Irons, Ernest E. 1929. The clinical evaluation of drugs. JAMA 93 (20): 1523–24.

Ishikawa, Kazuhiro, Masato Yamamoto, Donald T. Kishi, et al. 2005. New prospective payment system in Japan. American Journal of Health-System Pharmacy 62 (15): 617–19.

Jacobson, Peter. 2002. Strangers in the night: Law and medicine in the managed care era. New York: Oxford University Press.

Jamison, Douglas W., and Christina Jansen. 2000. Technology transfer and economic growth. Journal of Association of University Technology Managers 12: 24–35.

Japan Medical Association (JMA). 1951. Physician’s ethics code. Tokyo: JMA. Available at http://www.med.or.jp/english/02_princ.html (accessed 9 June 2009).

Japan Medical Association (JMA). 1951. Principles of ethics. Available at http://www.med.org.jp.english, about JMA/principles.html (accessed 9 June 2009).

Japan Medical Association (JMA). 1951. Remuneration of doctors, ethical codes for doctors. Tokyo: JMA.

Japan Medical Association (JMA). 2009. The JMA guidelines for physician’s professional ethics 2008. Japan Medical Association Journal 52 (2): 75–91.

Japan Medical Association (JMA), Committee on Bioethics. 1996. Social responsibility expected of doctors: In search of good professionalism. Journal of the Japan Medical Association 116 (3): 243–50.

Japan Pharmaceutical Manufacturers Association (JPMA). 1984. Fair competition rules of pharmaceutical manufacturers on gift-giving. Tokyo: JPMA.

Japan Pharmaceutical Manufacturers Association (JPMA). 1993. Guidelines on gift-giving to health care providers permissible under FTC rules. Tokyo: JPMA.

(p.344) Japan Pharmaceutical Manufacturers Association (JPMA). 1993. Guidelines on remuneration for case reporting allowable under FTC rules. Tokyo: JPMA.

Japan Pharmaceutical Manufacturers Association (JPMA). 1993. Promotional code of pharmaceuticals. Tokyo: JPMA.

Japan Pharmaceutical Manufacturers Association (JPMA). 2008. Promotion code for prescription drugs. 23 May. Tokyo: JPMA. Available at http://www.jpma.or.jp/english/issues/pdf/2007code_e.pdf (accessed 8 June 2009).

Jeong, Hyoung-Sun, and Jeremy Hurst. 2001. An assessment of the performance of the Japanese health care system. OECD Labour Market and Social Policy Occasional Papers. Available at http://www.oecd.org/dataoecd/35/28/34687614.pdf (accessed 10 November 2009).

Jha, Ashish K., Jonathan B. Perlin, Kenneth W. Kizer, et al. 2003. Effect of the transformation of the veterans affairs health care system on the quality of care NEJM 348 (22): 2218–27.

Johansen, Helle Krogh, and Peter C. Gotzche. 1999. Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA 282 (18): 1752–59.

Johns, Margaret Z. 2007. Informed consent: Requiring doctors to disclose off-label prescriptions and conflicts of interest. Hastings Law Journal 58 (5): 967–1024.

Johnston, Helen L. 1951. Rural health cooperatives. Public Health Bulletin No. 308. Washington, DC: Cooperative Research and Service Division, Farm Credit Administration, and Division of Medical and Hospital Resources, Public Health Service.

Joseph, John N., et al. 2009. Enforcement related to off-label marketing and use of drugs and devices: Where have we been and where are we doing? Journal of Health & Life Sciences Law 2 (2): 73–108.

Juppé, Alain. 1996. Discours de Alain Juppé, 15 Novembre 1995. Droit Social 3: 221–37.

Kanda, Hideki, and Curtis J. Milhaupt. 2003. Reconsidering legal transplants: Directors’ fiduciary duty in Japanese corporate law. American Journal of Comparative Law 51 (4): 887–901.

Kassirer, Jerome P. 1994. The use and abuse of practice profiles. NEJM 330 (9): 634–36.

Kassirer, Jerome P. 2005. On the take: How America’s complicity with big business can endanger your health. New York: Oxford University Press.

Kasza, Gregory J. 2002. War and welfare policy in Japan. Journal of Asian Studies 61 (2): 417–27.

Kasza, Gregory J. 2006. One world of welfare: Japan in comparative perspective. Ithaca, NY: Cornell University Press.

Katz, Jay. 1984. The silent world of doctor and patient. Baltimore, MD: Johns Hopkins University Press.

Katz, Elihu, and George Menzel. 1955. Social relations and innovation in the medical profession: the epidemiology of a new drug. Public Opinion Quarterly 19 (4): 337–72.

Keehan, Sean, Andrea Sisko, Christopher Truffer, et al. 2008. Health spending projections through 2017: The baby-boom generation is coming to Medicare. Health Affairs 27: 145–55.

Kelman, Steven. 1987. Making public policy: A hopeful view of American government. New York: Basic Books.

Kenpōren. 1990. History of Japanese NHI. Tokyo: Kenpōren.

(p.345) Kenpōren. 2007. Health insurance, long-term care insurance and health insurance societies in Japan 2007. Tokyo: Kenpōren.

Kikuni, Kenzō. 1984. Quality assurance programs in Japan. Japan Hospitals 3 (July): 29–31.

Kimura, Rihito. 1991. Fiduciary relationship and the medical profession: A Japanese view. In Ethics, trust, and the professions: Philosophical and cultural aspects, ed. D. Pellegrino, R. M. Veatch, and J. Langan, 235–45. Washington, DC: Georgetown University Press.

Kjaergard, Lise L., and Bodil Als-Nielsen. 2002. Association between competing interests and authors’ conclusions: Epidemiological study of randomized clinical trials published in the BMJ. British Medical Journal 325 (7358): 249–52.

Kodaka, Michio. 1986. Present status of hemodialysis in Japan. Journal of the Japanese Society for Dialysis Therapy 19: 1–21

Kodansha Encyclopedia of Japan. 1983. Tokyo: G. Itasaka, Kodansha America.

Kovner, Anthony R., and James R. Knickman. 2008. Jonas and Kovner’s health care delivery in the United States. 9th ed. New York: Springer.

Kozeki, Oshamu. 1995. Consequences of fixed-payment for dialysis. Banboo 164 (February): 68–72. Kyodo News, 30 March.

Krause, E. 1996. Death of the guilds: Professions, states, and the advance of capitalism, 1930 to the Present. New Haven, CT: Yale University Press.

Kredel, Frederick Evert, and John Hampton Hoch. 1939. Early relation of pharmacy and medicine in the United States. Journal of the American Pharmaceutical Association 28 (10): 702–7.

Krimsky, Sheldon. 2003. Science in the private interest: Has the lure of profits corrupted biomedical research? Lanham, MD: Rowman and Littlefield.

Krimsky, Sheldon, and L. S. Rothenberg. 2001. Conflict of interest policies in science and medical journals: Editorial practices and author disclosures. Science and Engineering Ethics 7 (2): 205–18.

Kumar, C. Raj. 2004. Corruption in Japan: Institutionalizing the right to information, transparency and the right to corruption-free governance. New England Journal of International and Comparative Law 10 (1): 465–66.

Kusserow, Richard P. 1989. Financial arrangements between physician and health care businesses: Report to Congress. Washington, DC: Office of the Inspector General-Department of Health and Human Services (OIG-DHHS).

Kusserow, Richard P. 1990. Ensuring appropriate use of laboratory services: A monograph. Washington, DC: OIG-DHHS.

Kusserow, Richard P. 1992. Promotion of prescription drugs through payment and gifts: Physicians’ perspectives. Washington, DC: OIG-DHHS.

La Berge, Ann E., and Mordechai Feingold. 1994. French medical culture in the nineteenth century. Amsterdam: Edition Rodopi B.V.

Lamy. 2009. Droit de la santé. Editions Lamy, Paris.

Laroque, Pierre, ed. 1983. The social institutions of France. London: Taylor and Francis.

Larroumet, Christian. 1990. La fiducie inspirée du trust. Paris: Recueil Dalloz.

Larson, Magali Sarfatti. 1977. The rise of professionalism. Berkeley: University of California Press.

Laubenthal, Connie. 1996. Physician’s office laboratory adviser. Part 1, Physician office laboratories, history of government regulation. Medical Laboratory Observer (p.346) (November). Available at http://findarticles.com/p/articles/mi_m3230/is_n11_v28/ai_18899710/ (accessed 13 November 2009).

Laufer, Joseph. 1939. Ethical and legal restrictions on contract and corporate practice of medicine. Law and Contemporary Problems 6 (4): 516–27.

Law, Sylvia A. 1976. Blue Cross: What went wrong? New Haven, CT: Yale University Press.

Le Pen, Claude. 1999. Les habit neufs d’Hippocrate. Paris: Calmann-Lévy.

Le Goff, Jacques. 1980. Les métiers et l’organisation du travail dans la France médiévale. In La France et les français, ed. M. François, 310–37. Gallimard.

Leake, Chauncey D. 1929. The pharmacologic evaluation of new drugs. JAMA 93 (21): 1632–34.

Lear, John. 1962. The unfinished story of Thalidomide. Saturday Review of Literature 45:35–43.

Leflar, Robert B. 1996. Informed consent and patients’ rights in Japan. Houston Law Review 33 (1): 1–112.

Leflar, Robert B. 2007. Law and patient safety in the United States and Japan. In Readings in comparative health law and bioethics, ed. T. S. Jost, 124–26. Durham, NC: Carolina Academic Press.

Leflar, Robert B. 2009. Unnatural deaths, criminal sanctions, and medical quality improvement in Japan. Yale Journal of Health Policy, Law and Ethics 9 (1): 11.

Leflar, Robert B., and Futoshi Iwata. 2005. Medical error as reportable event, as tort, as crime: A transpacific comparison. Widener Law Review 12 (1): 189–225.

Léonard, Jacques. 1981. La médecine entre les savoirs et les pouvoirs: Histoire intellectuelle et politique de la médecine française au XIXème siècle (Paris: Aubier, 1981).

Lexchin, Joel, Lisa A. Bero, Benjamin Djulbegovic, et al. 2003. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. British Medical Journal 326 (7400): 1167–70.

Liebrand, Wim B., David M. Messick, and Fred J. Wolters. 1986. Why we are fairer than others? A cross-cultural replication and extension. Journal of Experimental Social Psychology 22 (6): 590–604.

Light, Donald W. 2004. Ironies of success: A new history of the American health care “system.” Journal of Health and Social Behavior 45 (extra issue): 1–24.

Lincoln, James, and Arne L. Kalleberg. 1985. Work organization and workforce commitment: A study of plants and employees in the U.S. and Japan. American Sociological Review 50 (6): 738–60.

Lock, Margaret M. 1980. East Asian medicine in urban Japan. Berkeley: University of California Press.

Locke, John. [1689] 1960. Two treatises of government, ed. Peter Laslett. Cambridge: Cambridge University Press.

Long, Susan Orpett. 1987. Health care providers: Technology, policy, and professional dominance. In Health, illness, and medical care in Japan: Cultural and social dimensions, ed. E. Norbeck and M. Lock, 66–88. Honolulu: University of Hawaii Press.

Ludmerer, Kenneth M. 1999. Time to heal: American medical education from the turn of the century to the era of managed care. New York: Oxford University Press.

Luft, Harold S. 1987. Health maintenance organizations: Dimensions of performance. New Brunswick, NJ: Transaction Books.

Lydston, Frank G. 1899. The surgical commission man and surgical canvassing. Philadelphia Medical Journal 4 (1): 837–40.

(p.347) MacLeod, Gordon K., and M. Roy Schwartz. 1986. Faculty practice plans: Profile and critique. JAMA 256 (1): 58–62.

Maillard, Christian. 1986. Histoire de l’hôpital de 1940 à nos jours: Comment la santé est devenue une affaire d’état. Paris: Dunod.

Maine, Henry. 1932. Ancient law: Its connection with the early history of society and its relation to modern ideas. Boston: Beacon Press.

Marmor, Theodore R. 2000. The politics of Medicare. 2d ed. Hawthorne: Aldine de Gruyter.

Marrus, Michael R., Robert O. Paxton, and Stanley Hoffmann. 1995. Vichy France and the Jews. Stanford, CA: Stanford University Press.

Marshal, T. H. 1939. The recent history of professionalism in relation to social structure and social policy. Canadian Journal of Economics and Political Science 5 (3): 325–40.

Masuyama, Mikitaka, and John Creighton Campbell. 1996. The evolution of fee-schedule politics in Japan. In Containing health care costs in Japan, ed. N. Ikegami and J. C. Campbell, 265–77. Ann Arbor: University of Michigan Press.

May, Charles D. 1961. Selling drugs by educating physicians. Journal of Medical Education 36 (1): 1–23.

McCann, James C. 1958. Consideration of deduction and allocation of surgical fees by Blue Shield plans. JAMA 166 (6): 624–28.

McDonough, John. 1997. Tracking the demise of state hospital rate-setting. Health Affairs 16 (1): 142–49.

Mechanic, David. 1986. From advocacy to allocation: The evolving American health care system. New York: Free Press.

Mechanic, David. 2000. Managed care and the imperative for a new professional ethic. Health Affairs 19 (5): 100–11.

Mechanic, David. 2008. Rethinking medical professionalism: The role of information technology and practice innovation. Milbank Quarterly 86 (2): 368–88.

Medical Association of the State of Alabama. 1890. Report of the Board of Censors. Transactions of the Medical Association of the State of Alabama. Birmingham.

Mehlman, Maxwell J. 2006. Dishonest medical mistakes. Vanderbilt Law Review 59 (4): 1137–73.

Mény, Yves. 1990. La corruption de la république. Paris: Fayard.

Mény, Yves. 1997. France: The end of the republican ethic? In Democracy and corruption in Europe, ed. D. D. Porta and Y. Meny, 7–21. Paris: La Découverte.

Meyers, Harold B. 1970. The medical industrial complex. Fortune 81 (January), 1.

Ministry of Health, Labor, and Welfare (Japan), Central Social Insurance Medical Care Committee, Subcommittee on Price Setting. 1995. Report on pharmaceutical evaluation and price setting in foreign countries. March.

Milgram, Stanley. 1974. Obedience to authority. New York: Harper and Row.

Millard, Perry H. 1887. The propriety and necessity of state regulation of medical practice. JAMA 9 (16): 491.

Miller, Francis H. 1983. Secondary income from recommended treatment: Should fiduciary principles constrain physician behavior? In The new health care for profit: Doctors and hospitals in a competitive environment, ed. B. Gray, 153–69. Washington, DC: National Academies Press.

Millis, Harry Alvin. 1937. Sickness and insurance: A study of the sickness problem and health insurance. Chicago: University of Chicago Press.

(p.348) Mitchell, Alan. 1991. The function and malfunction of mutual aid societies in nineteenth century France. In Medicine and charity before the welfare state, ed. J. Barry and C. Jones, 172–89. New York: Routledge.

Mitchell, Jean M. 2007. Utilization changes following market entry by physician owned specialty hospitals. Medical Care Research and Review 64 (4): 395–415.

Mitchell, Jean M., and Elton Scott. 1992. Evidence of complex structure of physician joint ventures. Yale Journal on Regulation 9 (2): 489–520.

Mitchell, Jean M., and Jonathan H. Sunshine. 1992. Consequences of physicians’ ownership of health care facilities: Joint ventures in radiation therapy. NEJM 327 (21): 1497–501.

Moore, Don A., Daylian M. Cain, George Loewenstein, et al. 2004. Conflicts of interest: Challenges and solutions from law, medicine and organization settings. Cambridge: Cambridge University Press.

Moore, Don A., and George Loewenstein. 2004. Self-interest, automaticity, and the psychology of conflict of interest. Social Justice Research 17 (2): 189–202.

Moore, Wilbert E. 1971. The professions: Roles and rules. New York: Russell Sage Foundation.

Moret-Bailly, Joël. 2001. Les Déontologies. Aix-en-Provence: Presses Universitaires d’Aix-Marseille.

Moret-Bailly, Joël. 2002. Règles déontologiques et fautes civiles. Recueil Dalloz, 2820–24.

Moret-Bailly Joël. 2002. L’accès à la justice disciplinaire. Paris: Mission de recherche droit et justice.

Moret-Bailly, Joël. 2003. L’organisation juridique des compétences des professionnels de santé. In Modalités et conditions d’évaluation des compétences professionnelles des métiers de la santé. Rapport au ministre de l’éducation et au ministre de la santé, ed. Y. Matillon, 57–86. Paris: Ministre de la santé et des solidarités.

Moret-Bailly Joël. 2004. Les conflits d’intérêts des experts consultés par l’administration dans le domaine sanitaire. Revue Droit Sanitaire et Sociale 4: 855–71.

Moret-Bailly, Joël. 2004. Déontologie. In Dictionnaire de la justice, ed. L. Cadiet, 326–30. Paris: Presses Universitaires de France.

Moret-Bailly, Joël. 2009. Le rôle des experts au sein des agences de sécurité sanitaire, Annales de la Régulation, LGDJ 2: 327–43.

Morgan, John. 1937. A discourse upon the institution of medical schools in America. Baltimore, MD: Johns Hopkins University Press.

Morgenthaler, Jean-Louis. 1981. La mutualité française de 1945 à 1976: De la tradition au modernisme. Thèse présentée pour le doctorat au troisième cycle de sociologie, Université de Nancy II.

Morone, James A. 1990. The democratic wish: Popular participation and the limits of the American government. New York: Basic Books.

Morrein, E. Haavi. 1990. Physician investment and self-referral: A philosophical analysis of a contentious debate. Journal of Medicine and Philosophy 15 (4): 425–48.

Morris, Lewis, and Julie K. Taitsman. 2009. The agenda for continuing medical education—Limiting industry’s influence NEJM: 361 (25): 2478–82.

Muramatsu, Naoko, and Jersey Liang. 1999. Hospital length of stay in the United States and Japan: A case study of myocardial infarction patients. International Journal of Health Services 29 (1): 189–209.

(p.349) Nagele, Robin Locke, and Elizabeth B. Bradley. 2006. Physician-owned specialty hospital and hospital conflict-of-interest policies: Healthy competition or business opportunism? In Health Law Handbook 2006, ed. A. G. Gosfield, 691–725. St. Paul, MN: Thompson/West.

Nakano, Yutaka, and Hiroshi Ohama. 1998. Fee schedule made easy ’98. Tokyo: UtoBrain.

Nakajima, Chizu. 1999. Conflicts of interest and duty: A comparative analysis in Anglo-Japanese law. The Hague: Kluwer Law International.

National Medical Convention. 1847. Code of medical ethics. Archives of the American Medical Association, Proceedings of the National Medical Conventions held in Philadelphia, 1846, and New York City, 1847, 83–106. Chicago: AMA. Reprinted 1977 in Ethics in medicine: Historical perspectives and contemporary concerns, ed. Stanley J. Reiser, Arthur L. Dyck, and William J. Curran, 26–34. Cambridge, MA: MIT Press.

Needleman, Jack, Debora J. Chollet, and Jo Ann Lamphere. 1997. Hospital conversion trends. Health Affairs 6 (2): 187–95.

Niki, Ryu. 1993. Rapid increase in private multi-hospital systems in Japan. Paper presented at the Comparative Health Care Research Series, Stanford University.

Niki, Ryu. 1998. Integrated delivery systems in Japan: Brief summary of a national survey and future predictions. Paper presented at Pacific Research Center, Stanford University, 2 September.

Niki, Ryu. 1999. Hoken iryō fukushi fukugotai I [Integrated delivery systems].

Office of the U.S. Trade Representative. 2004. Third report to the leader on the U.S-Japan regulatory reform and competition policy initiative. http://www.mac.doc.gov/japan-korea/deregulation/2004–06–08-japan-factsheet.pdf.

Ogawa, Sumiko, Toshihiko Segawa, Guy Carrin, et al. 2003. Scaling up community health insurance: Japan’s experience with the 19th century Jyorei scheme. Health Policy and Planning 18 (3): 270–78.

Ohi, G., T. Hasegawa, H. Kumano, I. Kai, et al. 1986. Why are cadaveric renal transplants so hard to find in Japan? An analysis of economic and attitudinal aspects. Health Policy 6 (3): 269–78.

Ohnuki-Tierney, Emiko. 1984. Illness and culture in contemporary Japan: An anthropological view. Cambridge: Cambridge University Press.

Ohtani, Fujia. 1971. One hundred years of health progress in Japan. Tokyo: International Medical Foundation of Japan.

Okamoto, Etsuji. 2004. Public health of Japan, 2004. Tokyo: Japan Public Health Association.

Okamoto, Etsuji, and Kōzō Tatara. 2008. Public health of Japan, 2007. Tokyo: Japan Public Health Association.

Organization for Economic Cooperation and Development (OECD). 2004. Reviews of regulatory reform. Japan: Progress in implementing regulatory reform. No. 56, OECD Publishing. Available at http://www.oecd.org/dataoecd/56/2/32983995.pdf (accessed 10 November 2009).

Osler, William. 1906. Chauvinism in medicine. In Osler, Aequanimitas, with other addresses to medical students, nurses and practitioners of medicine, 277–306. 2d ed. Philadelphia: Blakiston.

Ouchi, William C. 1981. Theory Z: How American business can meet the Japanese challenge. Reading, MA: Addison-Wesley.

(p.350) Parsons, Talcott. 1968. Professions. In International encyclopedia of the social sciences, ed. D. Sills, 536–47. New York: Macmillan.

Patsopoulos, Nikolaos A., John P. A. Ioannidis, and Apostolos A. Analatos. 2006. Origin and funding of the most frequently cited papers in medicine: Database analysis. British Medical Journal 332 (7549): 1061–64.

Pekkanen, Robert. 2003. Molding Japanese civil society: State-structured incentives and the patterning of civil society. In The state of civil society in Japan, ed. F. J. Schwartz and S. J. Pharr, 117–34. Cambridge: Cambridge University Press.

Pekkanen, Robert, and Karla Simon. 2002. Taxation of not-for-profit organizations and their donors in Japan: Is this tax reform or not? International Journal of Not-for-Profit Law 4 (2/3): 1–5.

Petit, Donald W. 1970. The physician recognition award. JAMA 213 (10): 1668–70.

Podolsky, Scott H., and Jeremy A. Greene. 2008. A historical perspective of pharmaceutical promotion and physician education. JAMA 300 (9): 1071–73.

Polton, Dominique. 2004. Recent reforms affecting private health insurance in France. Euro Observer 6 (1): 4–5.

Powell, Margaret, and Masahira Anesaki. 1990. Health care in Japan. London: Routledge.

Puckner, W. A., and Paul Nicholas Leech. 1929. The introduction of new drugs. JAMA 93 (21): 1627–30.

Ramsey, Mathew. 1988. Professional and popular medicine in France, 1770–1830. Cambridge: Cambridge University Press.

Ramsey, Matthew. 1994. Academic medicine and medical industrialism: The regulation of secret remedies in nineteenth-century France. In French medical culture in the nineteenth century, ed. A. La Berge and M. Feingold, 25–32. Amsterdam: Edition Rodopi B.V.

Raoux, F. 1979. Naissance de la corporation médicale 1879–1943. Thèse de médecine, Faculté de St. Antoine, Paris.

Rayack, Elton. 1967. Professional power and American medicine: The economics of the American Medical Association. Cleveland: World Book.

Rebecq, Geneviève. 2007. Protection sociale. Paris: Editions de Juris Classeur.

Reed, Louis S. 1967. Private health insurance: Coverage and financial experience, 1940–66. Social Security Bulletin 30 (November): 3–22.

Rehder, Robert R. 1965. Communication and opinion formation in a medical community: The significance of the detail man. Journal of the Academy of Management 8 (4): 282–91.

Reinhardt, Uwe E. 1996. A social contract for 21st century health care: Three-tier health care with bounty hunting. Health Economics 5 (6): 479–99.

Reinhardt, Uwe. 1996. Is the target-income hypothesis an economic heresy? Medical Care Research and Review 53 (3): 274–87.

Reinhardt, Uwe E. 2000. The economics of for-profit and not-for-profit hospitals. Health Affairs 19 (6): 178–86.

Relman, Arnold S. 1980. The new medical-industrial complex. NEJM 303 (17): 963–70.

Relman, Arnold S. 1984. Dealing with conflicts of interest. NEJM 310 (18): 1182–83.

Relman, Arnold S. 2001. Separating continuing medical education from pharmaceutical marketing. JAMA 285 (15): 2009–12.

Relman, Arnold S. 2007. A second opinion: Rescuing America’s health care. New York: Public Affairs.

(p.351) Relman, Arnold S., and Uwe E. Reinhardt. 1986. An exchange on for-profit health care. In For-profit enterprise in health care, ed. B. H. Gray, 209–23. Washington, DC: National Academy Press.

Reynaud. 1989. Les règles du jeu: L’action collective et la régulation sociale. Paris: Armand Colin.

Rice, Thomas. 2003. The economics of health reconsidered. 2d ed. Chicago: Health Administration Press.

Richter, Judith. 2005. Global strategy for infant and young child feeding. Geneva: International Baby Food Action Network.

Robinson, James C. 1999. Blended payment methods in physician organizations under managed care. JAMA 282 (13): 1258–63.

Robinson, James C. 2001. The end of managed care. JAMA 285 (20): 2622–28.

Robinson, James C. 2001. Theory and practice in the design of physician payment incentives. Milbank Quarterly 79 (2): 149–77.

Robinson, James C., and Lawrence Casalino. 2001. Reevaluation of capitation contracting in New York and California. Health Affairs 20 (4): W3–W9.

Rochaix, Maurice. 1996. Les questions hospitalières: De la fin d l’ancien régime à nos jours. Paris: Berger-Levrault.

Rodwin, Marc A. 1989. Physicians’ conflicts of interests: The limitations of disclosure. NEJM 321 (20): 1405–8.

Rodwin, Marc A. 1992. The organized American medical profession’s response to financial conflicts of interest: 1890–1992. Milbank Quarterly 70 (4): 703–41.

Rodwin, Marc A. 1993. Medicine, money and morals: Physicians’ conflicts of interest. New York: Oxford University Press.

Rodwin, Marc A. 1994. Patient accountability and quality of care: Lessons from medical consumerism and the patients’ rights, women’s health and disability rights movements. American Journal of Law and Medicine 20 (1&2): 147–67.

Rodwin, Marc A. 1995. Strains in the fiduciary metaphor: Divided physician loyalties and obligations in a changing health care system. American Journal of Law and Medicine 21 (2&3): 241–57.

Rodwin, Marc A. 1995. Conflicts in Managed Care. NEJM 332 (9): 604–7.

Rodwin, Marc A. 1999. Backlash: Prelude to managing managed care. Journal of Health Politics, Policy and Law 24 (5): 1115–26.

Rodwin, Marc A. 1999. Exit and voice in American health care. Michigan Journal of Law Reform 32 (4): 1041–67.

Rodwin, Marc A. 2001. Consumer voice and representation in health care. Journal of Health Law 34 (2): 223–72.

Rodwin, Marc A. 2001. The politics of evidence-based medicine. Journal of Health Politics and Law 26 (2): 439–46.

Rodwin, Marc A. 2004. The dark side of a consumer driven health care system. Frontiers of Health Care Management 19:31–34.

Rodwin, Marc A. 2007. Medical commerce, physician entrepreneurialism, and conflicts of interest. Cambridge Quarterly of Healthcare Ethics 16 (4): 387–97.

Rodwin, Marc A. 2010. The metamorphosis of managed care. Journal of Law, Medicine, & Ethics 36 (2): 252–364.

(p.352) Rodwin, Marc A. 2011. Patient appeals as policy disputes: Individual and collective action in managed care. In Impatient voices: Patients as policy actors, ed. B. Hoffman, N. Tomes, R. Grob, et al. New Brunswick, NJ: Rutgers University Press.

Rodwin, Marc A., and Estuji Okomoto. 2000. Physicians’ conflict of interest in Japan and the United States: Lessons for the United States. Journal of Health Politics, Policy and Law 25 (2): 343–75.

Rodwin, Marc A., Hak Chang, and Jeffrey Clausen. 2006. Malpractice premiums and physician income: Perceptions of a crisis conflict with empirical evidence. Health Affairs 25 (3): 750–58.

Rodwin, Marc A., Hak J. Chang, Melissa M. Ozaeta, et al. 2008. Malpractice premiums in Massachusetts, a high-risk state: 1975 to 2005. Health Affairs 27 (3): 835–44.

Rodwin, Victor G. 1984. The health planning predicament: France, Québec, England, and the United States. Berkeley: University of California Press.

Rodwin, Victor G., and Claude Le Pen. 2004. Health care reform in France: The birth of state-led managed care. NEJM 351 (22): 2259–62.

Rodwin, Victor, R. J. Launois, B. Majnoni d’Intignano, and J. C. Stéphan. 1985. Les réseaux de soins coordonnés (RSC): Propositions pour une réforme profonde du système de santé. Revue Française des Affaires Sociales 1 (January/March): 37–61.

Roemer, Milton I., and Jay W. Friedman. 1971. Doctors in hospitals: Medical staff organizations and hospital performance. Baltimore, MD: Johns Hopkins University Press.

Roemer, Milton I., and Max Shain. 1959. Hospital utilization under insurance. Ithaca, NY: Cornell University School of Business and Public Administration.

Rogers, Mabry E., and Stephen B. Young. 1975. Public office as a public trust: A suggestion that impeachment for high crimes and misdemeanors implies a fiduciary standard. Georgetown Law Journal 63 (5): 1025–49.

Röhl, Wilhelm 2005. A history of law in Japan since 1868. Leiden: Brill.

Romains, Jules. [1925] 2000. Knock: Ou le triomphe de la médecine: Comédie en trois actes. Paris: Gallimard; Harley Granville-Barker, trans. 1935. Doctor Knock: A Comedy in Three Acts. London, Sidgwick and Jackson.

Rorem, C. Rufus. 1931. Private group practice clinics. Chicago: University of Chicago Press.

Rorem, C. Rufus, and Robert P. Fischelis. 1932. The costs of medicine. Committee on the Cost of Medical Care, No. 14. Chicago: University of Chicago Press.

Rosanvallon, Pierre. 2008. L’état en France de 1789 à nos jours. Paris: Seuil.

Rosen, George. 1974. From medical police to social medicine: Essays on the history of health care. New York: Sciences History Publications.

Rosenberg, Charles. 1974. Social class and medical care in nineteenth-century America: The rise and fall of dispensary. Journal of the History of Medicine and the Allied Sciences 29 (1): 32–54.

Rosner, David. 1982. A once charitable enterprise: Hospitals and health care in Brooklyn and New York, 1885–1915. Cambridge: Cambridge University Press.

Ross, Joseph S., Kevin P. Hill, David S. Egilman, et al. 2008. Guest authorship and ghostwriting in publications related to Rofecoxib: A case study of industry documents from Rofecoxib litigation. JAMA 299 (15): 1800–1812.

Roth, Julius A. 1974. Professionalism: The sociologists’ decoy. Work and Occupations 1 (1): 6–23.

(p.353) Rothman, David J. 1991. Strangers at the bedside: A history of how law and bioethics transformed medical decision making. New York: HarperCollins.

Rothman, David J. 1993. A century of failure: Health care reform in America. Journal of Health Politics, Policy and Law 18 (2): 271–86.

Rothman, David J., Walter J. McDonald, Carol D. Berkowitz, et al. 2009. Professional medical associations and their relationships with industry: A proposal for controlling conflicts of interest. JAMA 301 (13): 1367–72.

Rousseau, Jean-Jacques. [1762] 2003. The social contract and discourses, trans. G. D. H. Cole. Mineola, NY: Dover.

Rucker, T. Donald. 1972. Economic problems in drug distribution. Inquiry 9 (3): 43.

Rupp, Katherine. 2003. Gift-giving in Japan: Cash, connections, cosmologies. Stanford, CA: Stanford University Press.

Rayack, Elton. 1967. Professional power and American medicine: The economics of the American Medical Association. Cleveland, OH: World Book.

Sage, William M., David A. Hyman, and Warren Greenberg. 2003. Why competition law matters to health care quality. Health Affairs 22 (2): 31–43.

Sage, William M. 2007. Some principals require principles: Why banning “conflicts of interest” won’t solve incentive problems in biomedical research, Texas Law Review 85 (6): 1413–64.

Salon, Serge, and Jean-Charles Savignac. 2009. Code de la fonction publique. Paris: Dalloz-Sirey.

Sams, Crawford F. 1998. “Medic”: The mission of an American military doctor in occupied Japan and war-torn Korea. Armonk, NY: M.E. Sharp

Sand, R. 1948. Vers la médecine sociale. Liège, Belgique: Baillere.

Sandier, Simone, Valérie Paris, and Dominique Polton. 2004. Health care systems in transition: France. Copenhagen: European Observatory on Health Systems and Policies.

Sasamori, Norio. 1982 The present condition of the human dry dock in Japan and its outlook for the future. Japan Hospitals 1: 49–55.

Sawaniski, K. 1990. Follow up on dialysis patients initiated below serum creatinine level 8.0 mg/dl. Journal of Japanese Society of Dialysis Therapy 23: 1–10.

Schlesinger, Mark. 1997. Countervailing agency: A strategy of principled regulation under managed competition. Milbank Quarterly 75 (1): 35–87.

Schlesinger, Mark. 2002. A loss of faith: The sources of reduced political legitimacy for the American medical profession. Milbank Quarterly 80 (2): 185–235.

Schlesinger, Mark J., Bradford H. Gray, and Krista M. Perreira. 1997. Medical professionalism under managed care: The pros and cons of utilization review. Health Affairs 16 (1): 106–24.

Schmidt, Dominique. 1999. Les conflits d’intérêts dans la société anonyme. Paris: Joly.

Schwartz, Frank J., and Susan J. Pharr, eds. 2003. The state of civil society in Japan. Cambridge: Cambridge University Press.

Schwartz, Jerome L. 1965. Early history of prepaid medical care plans. Bulletin of the History of Medicine 39 (5): 450–75.

Searle, John G., L. D. Barney, Francis Boyer, et al. 1961. The pharmaceutical industry. Journal of Medical Education 36 (1): 24–32.

Seikyō, Iryōbukai. 1982. Iryō seikyō no rekishi to tokuchō [The history and characteristics of health care cooperatives]. Tokyo: Iryō Seikyō.

(p.354) Sevringhaus, Elmer L. 1953. Interdependence of the medical profession and the pharmaceutical industry. JAMA 152 (16): 1522–25.

Sewell, William H., Jr. 1980. Work and revolution in France: The language of labor from the old regime to 1848. Cambridge: Cambridge University Press.

Shaw, George Bernard. [1913] 1988. Preface. The doctor’s dilemma: A tragedy. Baltimore, MD: Penguin.

Shimm, David S. 1996. Conflicts of interest in relations between physicians and the pharmaceutical industry. In Conflicts of interest in clinical practice and research, ed. R. Spece, D. S. Shimm, and A. E. Buchanan, 321–57. New York: Oxford University Press.

Shoji, Arahira, and Onishi Hironari. 1999. Reform of the Japanese health insurance system. International Social Security Review 52 (2): 101–8.

Shyrock, Richard Harrison. 1967. Medical licensing in America, 1650–1965. Baltimore, MD: Johns Hopkins University Press.

Sieyès, Emmanuel Joseph. [1789] 1964. What is the third estate? trans. M. Blondel, ed. S. E. Finer. New York: Praeger.

Sigerist, Henry E. 1951. A history of medicine. New York: Oxford University Press.

Silverman, Milton, and Philip R. Lee. 1974. Pills, profits and politics. Berkeley: University of California Press.

Simmons, George H. 1908. The Abbott alkaloidal company—high finance and methods of working the medical profession. JAMA 50 (11): 895–900.

Smith, Donald H. 1997. Wishful thinking about unions. Physician News Digest. Available at www.physiciansnews.com/discussion/smith.html (accessed 4 September 2007).

Smith, Richard. 2006. The trouble with medical journals. London: Royal Society of Medicine Press Ltd.

Smith, Timothy B. 1998. The social transformation of hospitals and the rise of medical insurance in France, 1914–1944. Historical Journal 41 (4): 1055–87.

Smith, Timothy B. 2003. Creating the welfare state in France: 1880–1940. Montreal: McGill-Queen’s University Press.

Snoke, Albert W. 1958. The future role of hospitals in medical care. American Journal of Public Health 48 (4): 468–72.

Somers, Herman Miles, and Anne Ramsay Somers. 1961. Doctors, patients, and health insurance. Washington, DC: Brookings Institution.

Spece, Roy, David. S. Shimm, and Alan. E. Buchanan. 1996. Conflicts of interest in clinical practice and research. New York: Oxford University Press.

Spingarn, Roger W., Jesse A. Berlin, and Brian L. Strom. 1996. When pharmaceutical manufacturers’ employees present grand rounds, what do residents remember? Academic Medicine 1 (1): 86–88.

Starr, Paul. 1982. The social transformation of American medicine. New York: Basic Books.

Stearns, Norman S., Marjorie E. Getchell, and Robert A. Gold. 1971. Continuing medical education in community hospitals: A manual for program development. Boston: Massachusetts Medical Society.

Steffen, Monika. 1983. Régulation, politique et stratégies professionnelles: Médecine libérale et émergence des centres de santé. Thèse de science politique, Institut d’Etudes Politiques, Université des Sciences Sociales de Grenoble.

(p.355) Steffen, Monika. 1987. The medical profession and the state in France. Journal of Public Policy 7 (2): 189–208.

Steffen, Monika. 1989. Privatization in French health politics: Few projects and little outcome. International Journal of Health Services 18 (4): 651–61.

Steffen, Monika. 2005. Health governance in Europe: Issues, challenges, and theories. London: Routledge.

Steffen, Monika. 2010. The French health care system: Liberal universalism. Journal of Health Politics, Policy and Law 35 (3): 336–69.

Steffan, Monika, and Wolfram Lamping. 2009. The “chaordic” dynamics of integration. Social Science Quarterly 90 (5): 1361–79.

Steinbrook, Robert. 2005. Financial conflicts of interest and the Food and Drug Administration’s advisory committees. NEJM 353 (2): 116–18.

Steinbrook, Robert. 2006. For sale: Physicians’ prescribing data. NEJM 354 (26): 2745–47.

Steinbrook, Robert. 2007. Financial support of continuing education in the health professions. In Continuing education in the health professions: Improving healthcare through lifelong learning, ed. H. M. Russell and R. S. Fletcher, 104–26. Available at www.joshiahmacyfoundation.org (accessed 10 November 2009).

Steinman, Michael A., Lisa A. Bero, Mary-Margaret Chren, et al. 2006. Narrative review: The promotion of Gabapentin: An analysis of internal industry documents. Annals of Internal Medicine 145 (4): 284–93.

Steinwald, Bruce, and Duncan Neuhaurser. 1970. The role of the proprietary hospital. Law and Contemporary Problems 35 (4): 824.

Steslicke, William E. 1973. Doctors in politics: The political life of the Japan Medical Association. New York: Praeger.

Steslicke, William E. 1982. Development of health insurance policy in Japan. Journal of Health Politics, Policy and Law 7 (1): 197–226.

Stevens, Rosemary. 1971. American medicine and the public interest. New Haven, CT: Yale University Press.

Stevens, Rosemary. 1989. In sickness and in wealth: American hospitals in the twentieth century. New York: Basic Books.

Stevez-Abe, Margarita. 2003. State-society partnership in the Japanese welfare state. In The state of civil society in Japan, ed. F. J. Schwartz and S. J. Pharr, 152–74. Cambridge: Cambridge University Press.

Stone, Deborah. 1980. The limits of professional power: National health care in the Federal Republic of Germany. Chicago: University of Chicago Press.

Stone, Deborah. 2008. The Samaritan rebellion. Ch. 4 in The Samaritan’s dilemma: Should government help your neighbor? New York: Nation Books.

Suda, Yuko. 2006. Devolution and privatization proceed and centralized system maintained: A twisted reality faced by Japanese nonprofit organizations. Nonprofit and Voluntary Sector Quarterly 35 (3): 430–52.

Sugerman-Brozan, Alex, and James Woolman. 2005. Drug spending and the average wholesale price: Removing the AWP albatross from Medicaid’s neck. Pharmaceutical Law & Industry Report 3 (35): 1–8.

Sugita, Satoru. 1989. A historical study of Iyaku-Bungyō [the separation of the dispensary from medical practice] in Japan. In History of the doctor-patient relationship: Proceedings of the 14th international symposium on the comparative history of (p.356) medicine—East and West, ed. Y. Kawakita, S. Sakai, and Y. Otsuka. Tokyo: Ishiyaku EuroAmerica.

Sugita, Yoneyuki. 2007. Universal health insurance: The unfinished reform of Japan’s health care system. In Democracy in occupied Japan: The U.S. occupation and Japanese politics and society, ed. M. E. Caprio and Y. Sugita. Routledge, London, 2007.

Suleiman, Ezra N. 1978. Elites in French society. Princeton, NJ: Princeton University Press.

Sullivan, William 1995. Work and integrity: The crisis and promise of professionalism in America. New York: HarperCollins.

Sullivan, William M. 2004. Can professionalism still be a viable ethic? The Good Society 13 (1): 15–20.

Sullivan, William M. 2004. What is left of professionalism after managed care? Hastings Center Report 29 (2): 7–13.

Supreme Commander of the Allies Powers (SCAP), General Headquarters, Social Security Mission. 1947. Report of the social security mission. Papers of George F. Rohlick, Library, Special Collections Dept., SUNY Albany.

Supreme Commander for the Allied Powers. 1948. Public health and welfare in Japan, with Annex and Charts. Tokyo: The Commander.

Swart, K. W. 1949. Sale of offices in the seventeenth century. The Hague: Martinus Nijhoff.

Takagi, Yasuo. 1992. Effects of per-diem payment method in geriatric care: Changes in pharmaceutical and laboratory costs and ADL of the inpatients. Medicine and Society 2 (1): 43–62.

Takahashi, Mutsuko. 1997. The emergence of welfare society in Japan. Brookfield: Ashgate.

Takahashi, Takeshi. 1974. Social security for workers. In Workers and employers in Japan: The Japanese employment relations system, ed. K. Okochi, B. Karsh, and S. B. Levine, 442–43. Princeton, NJ: Princeton University Press.

Takemi, Tarō. 1982. A History of the Japan Medical Association. In Takemi, Socialized medicine in Japan: Essays, papers and addresses. Tokyo: JMA.

Talcott, Paul David. 1999. Why the weak can win: Healthcare policies in postwar Japan. Ph.D. diss., Harvard University.

Tanti-Hardouin, Nicolas. 2005. Le système de santé: La recomposition de l’offre hospitalière. La santé: Cahiers Français 324: 60–64.

Tanti-Hardouin, Nicolas. 1996. L’hospitalisation privée: Crise identitaire et mutation sectorielle. Paris: La Documentation Française.

Tatara, Kōzō, and Estuji Okamoto. 2009. Japan: Health system review. Health Systems in Transition 11 (5). Available from European Observatory on Health Systems and Policies at http://www.euro.who.int/Document/E92927.pdf (accessed 10 November 2009).

Tawney, R. H. 1920. The acquisitive society. New York: Harcourt Brace.

Temin, Peter. 1980. Taking your medicine: Drug regulation in the United States. Cambridge. MA: Harvard University Press.

Theil, Pierre. 1943. Le corps médical devant la médecine sociale. Paris: Librairie Bailliere. Université de Paris X.

Thompson, Dennis F. 1993. Understanding financial conflicts of interest. NEJM 329 (8): 573–76.

(p.357) Thouvenin, Dominique. 1982. Le secret médical et l’information du malade. Lyon: Presses Universitaires de Lyon.

Totten, George Oakley. 1966. The social democratic movement in prewar Japan. New Haven, CT: Yale University Press.

U.S. Department of Health, Education, and Welfare (HEW), Office of the Secretary, Task Force on Prescription Drugs. 1968. The drug makers and the drug distributors. Washington, DC: Government Printing Office.

U.S. Department of Health and Human Services (DHHS), Office of the Inspector General (OIG). 1988. Physician drug dispensing: An overview of state regulation. Washington, DC: DHHS.

U.S. Federal Trade Commission (FTC). 1958. Economic report on antibiotics manufacturers. Washington, DC: Government Printing Office.

U.S. General Accounting Office (GAO). 2003. Specialty hospitals: Information on national market share, physician ownership and patients served. Washington, DC: Government Printing Office.

U.S. House of Representatives. 1987. Hearing before the Committee on Energy and Commerce, Subcommittee on Health and the Environment. 1987. Physician dispensing of drugs: Hearings on H.R. 2093, 1st session, 21 April.

U.S. House of Representatives, Subcommittee on Health and the Environment, Committee on Energy and Commerce. 1989. Medicare and Medicaid initiatives hearings, 1st Session. 8 June.

U.S. House of Representatives, Subcommittee on Health, Committee on Ways and Means. 1993. Physician ownership and referral arrangements. 1st Session, vol. 2, 20 April.

U.S. Senate, 88th Congress. 1965. Subcommittee on Antitrust and Monopoly, Committee on the Judiciary. Physician ownership in pharmacies and drug companies.

U.S. Senate, 90th Congress. 1967. Subcommittee on Antitrust and Monopoly, Committee on Judiciary. The medical restraint of trade act.

U.S. Senate, 98th Congress. 1961–1962. Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary. Drug industry antitrust act (S. 1551).

U.S. Senate, Committee on the Judiciary, Subcommittee on Antitrust and Monopoly. 1961. Administered prices. drugs. Study of Administered Prices in the Drug Industry.

U.S. Senate, Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, 1961. Pursuant to S. Res. 52 Administered prices drugs. 1st Session. Washington, DC: Government Printing Office.

U.S. Senate, Committee on the Judiciary, U.S. Senate, Subcommittee on Antitrust and Monopoly. 1961. Administered prices, drugs, Report No. 448. Washington, DC: Government Printing Office.

U.S. Senate, Committee on Labor and Human Resources. 1990. Advertising, marketing and promotion. December 11 and 12.

U.S. Senate, Select Committee on Small Business, Subcommittee on Monopoly 1968. Present status of competition in the pharmaceutical industry. Washington, DC: Government Printing Office.

U.S. Senate, Select Committee on Small Business, Subcommittee on Monopoly. 1969. Present status of competition in the pharmaceutical industry. Washington, DC: Government Printing Office.

(p.358) U.S. Senate, Select Committee on Small Business, Subcommittee on Monopoly. 1971. Effect of promotion and advertising of over-the-counter drugs on competition, small business, and the health and welfare of the public. Washington, DC: Government Printing Office.

U.S. Senate, Subcommittee on Health, Committee on Labor and Public Welfare, Examination of the pharmaceutical industry: Hearings on Section 3441 and Section 966, Part 3, 8 March, 1974, 12, 13, 1974. Washington, DC: Government Printing Office.

Veatch, Robert M. 1991. Patient-physician relationship. The patient as partner, part II. Bloomington: Indiana University Press.

Vedula, S. Swaroop, Lisa Bero, Roberta W. Scherer, et al. 2009. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. NEJM 361 (20): 1963–71.

Wagner, Tobias. 1959. Ethical pharmaceutical promotion: The workings and philosophies of the pharmaceuticals industry. New York: National Pharmaceutical Council.

Wassenaar, John D., and Sara L. Thran. 2003. Physician socioeconomic statistics 2003. Chicago: AMA.

Watkins, Michael. 2004. The medical technology industry and Japan (A). Cambridge, MA: Harvard Business School, Case No. 9–904–018.

Waud, Douglas.R. 1992. Pharmaceutical promotions—a free lunch? NEJM 327(5):351–53.

Webb, Sydney, and Beatrice Webb. 1917. Special supplement on professional associations, parts 1, 2. New Statesmen 9 (211) (April 21): 1–24.

Weindling, Paul. 1991. The modernization of charity in nineteenth-century France and Germany. In Medicine and charity before the welfare state, ed. Jonathan Barry and Colin Jones, 190–206. New York: Routledge.

Weiler, Paul C., Howard H. Hiatt, Joseph P. Newhouse, et al. 1993. A measure of malpractice: Medical injury, malpractice litigation, and patient compensation. Cambridge, MA: Harvard University Press.

Weller, Charles. 1985. “Free choice” as a restraint of trade, and the counterintuitive contours of competition. Health Matrix 3 (2): 3–23.

Wilensky, Harold L. 1964. The professionalization of everyone? American Journal of Sociology 70 (2): 137–58.

Williams, Greer. 1952. The Columbus five-year cure for fee-splitting. Modern Hospital 78 (6): 67–69, 94–95.

Wilsford, David. 1991. Doctors and the state: The politics of health care in France and the United States. Durham, NC: Duke University Press.

Wilsford, David. 1993. The state and medical profession in France. In The changing medical profession: An international perspective, ed. F. W. Hafferty and J. B. McKinlay, 124–37. New York: Oxford University Press.

Wilson, Timothy D., and Nancy Brekke. 1994. Mental contamination and mental correction: Unwanted influences on judgments and evaluations. Psychological Bulletin 116 (1): 117–42.

Winfield, Percy H. 1925. The chief sources of English legal history. Cambridge, MA: Harvard University Press.

Wing, Kenneth. 1998. The law and American health care. New York: Aspen Law and Business.

Witz, Claude. 1981. La fiducie en droit privé français. Paris: Economica.

(p.359) Wocher, John C. 1994. The Japanese health care system: Planning the extinction of the private hospitals. Japan Hospitals 13 (July): 37–43.

Wocher, John. C. 1997. TQM/CQI efforts in Japanese hospitals—Why not? In The effectiveness of CQI in health care: Stories from a global perspective, ed. V. A. Kazandjian, 51–107. Milwaukee, WI: ASQ Quality Press.

Wolman, Dianne Miller, Andrea L. Kalfoglou, and Lauren LeRoy. 2000. Medicare laboratory payment policy: Now and in the future. Washington D.C.: National Academy Press.

Yamagami, M., and Y. Seoka. 1995. Health economics analysis on dialysis treatment. Banboo 163 (January): 64–68.

Yoshikawa, Aki. 1993. Doctors and hospitals in Japan. In Japan’s health system: Efficiency and effectiveness in universal care, ed. D. I. Okimoto and A. Yoshikawa, 63–89. Washington, DC: Faulkner and Gray.

Yumiko, Nishimura, and Aki Yoshikawa. 1993. A brief history of Japan’s passage to the universal health insurance system. In Japan’s health system: Efficiency and effectiveness in universal care, ed. D. I. Okimoto and A. Yoshikawa, 11–19. Washington, DC: Falkner and Gray.

Zola, Irving Kenneth. 1972. Medicine as an institution of social control. Social Review 20 (487): 487–504.

Zoller, Elisabeth. 2008. Introduction to public law: A comparative study. Koninklijke Bill: Martinus Nijhoff. (p.360)